<DOC>
	<DOCNO>NCT01309373</DOCNO>
	<brief_summary>The purpose study estimate level symptomatic psychosocial remission patient schizophrenia schizoaffective disorder standard clinical practice function degree adherence antipsychotic treatment . The secondary objective study level community integration patient include study , influence factor , analyze role various sociodemographic factor , factor related course disease psychopathological status patient community integration remission , analyze potential predictor favorable course ( symptomatic psychosocial remission ) poor course ( symptomatic psychosocial remission ) , assess impact treatment adherence change functional community integration status patient ( base occupation , independence level , degree disability variable ) , assess significance premorbid ( academic social ) adjustment symptomatic functional remission community integration status patient correlate level insight remission integration status patient .</brief_summary>
	<brief_title>An Epidemiological Study Assess Psychosocial Symptomatic Remission Community Integration Status Patients With Schizophrenia</brief_title>
	<detailed_description>This retrospective , cross-sectional , non-interventional observational , cohort epidemiological study conduct outpatient mental health facility set patient schizophrenia . The inclusion two patient cohort contemplate , recruit mental health facility . One cohort involve patient estimate inadequate adherence antipsychotic treatment , consist patient adequate adherence treatment . N/A</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>Patients schizophrenia schizoaffective disorder followedup mental health facility Whose clinical record recent year may access Who sign informed consent , state he/she understands study purpose requirement give consent participate study In psychiatrist main caregiver may estimate degree adherence antipsychotic treatment last two year Not hospitalize acute disorder unit last 12 month Patients psychiatric disease schizophrenia schizoaffective disorder diagnose severe moderate mental retardation , organic disorder personality , and/or severe and/or disable neurological disease Patients actively participate clinical trial/study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Remission</keyword>
	<keyword>Psychosocial</keyword>
	<keyword>Symtomatic</keyword>
	<keyword>Integration</keyword>
	<keyword>Schizoaffective</keyword>
	<keyword>Adherence</keyword>
</DOC>